These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29595317)

  • 1. Quantitative Assessment of Immunohistochemistry Laboratory Performance by Measuring Analytic Response Curves and Limits of Detection.
    Sompuram SR; Vani K; Schaedle AK; Balasubramanian A; Bogen SA
    Arch Pathol Lab Med; 2018 Jul; 142(7):851-862. PubMed ID: 29595317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytic Response Curves of Clinical Breast Cancer IHC Tests.
    Vani K; Sompuram SR; Schaedle AK; Balasubramanian A; Bogen SA
    J Histochem Cytochem; 2017 May; 65(5):273-283. PubMed ID: 28438091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Linear Range HER2/Estrogen Receptor/Progesterone Receptor IHControls for Daily Quality Assurance.
    Sompuram SR; Vani K; Ryan L; Johnson C; Szabolcs M; Peruyero L; Balaton A; Pierrot S; Joseph L; Pilichowska M; Naber S; Goldsmith J; Green S; Bogen SA
    Am J Clin Pathol; 2023 Mar; 159(3):274-282. PubMed ID: 36779320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program.
    Francis GD; Dimech M; Giles L; Hopkins A
    J Clin Pathol; 2007 Nov; 60(11):1277-83. PubMed ID: 17259294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.
    Pu T; Shui R; Shi J; Liang Z; Yang W; Bu H; Li Q; Zhang Z;
    BMC Cancer; 2019 Oct; 19(1):978. PubMed ID: 31640622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardizing Immunohistochemistry: A New Reference Control for Detecting Staining Problems.
    Sompuram SR; Vani K; Tracey B; Kamstock DA; Bogen SA
    J Histochem Cytochem; 2015 Sep; 63(9):681-90. PubMed ID: 25940339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.
    Wesseling J; Tinterri C; Sapino A; Zanconati F; Lutke-Holzik M; Nguyen B; Deck KB; Querzoli P; Perin T; Giardina C; Seitz G; Guinebretière JM; Barone J; Dekker L; de Snoo F; Stork-Sloots L; Roepman P; Watanabe T; Cusumano P
    Virchows Arch; 2016 Sep; 469(3):297-304. PubMed ID: 27377889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Importance of Epitope Density in Selecting a Sensitive Positive IHC Control.
    Vani K; Sompuram SR; Schaedle AK; Balasubramanian A; Pilichowska M; Naber S; Goldsmith JD; Chang KG; Noubary F; Bogen SA
    J Histochem Cytochem; 2017 Aug; 65(8):463-477. PubMed ID: 28665229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Web-based training for quality improvement between a field immunohistochemistry laboratory in Nigeria and its United States-based partner institution.
    Oluwasola AO; Malaka D; Khramtsov AI; Ikpatt OF; Odetunde A; Adeyanju OO; Sveen WE; Falusi AG; Huo D; Olopade OI
    Ann Diagn Pathol; 2013 Dec; 17(6):526-30. PubMed ID: 24095629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
    Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
    Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
    Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
    Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCR.
    Caselli E; Pelliccia C; Teti V; Bellezza G; Mandarano M; Ferri I; Hartmann K; Laible M; Sahin U; Varga Z; Lupi C; Stracci F; Sidoni A
    PLoS One; 2021; 16(9):e0255580. PubMed ID: 34555047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening.
    Rhodes A; Jasani B; Balaton AJ; Barnes DM; Miller KD
    J Clin Pathol; 2000 Sep; 53(9):688-96. PubMed ID: 11041059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions.
    Garuti A; Rocco I; Cirmena G; Chiaramondia M; Baccini P; Calabrese M; Palermo C; Friedman D; Zoppoli G; Ballestrero A
    Gynecol Oncol; 2014 Feb; 132(2):389-96. PubMed ID: 24269902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interlaboratory comparison of immunohistochemical testing for HER2: results of the 2004 and 2005 College of American Pathologists HER2 Immunohistochemistry Tissue Microarray Survey.
    Fitzgibbons PL; Murphy DA; Dorfman DM; Roche PC; Tubbs RR;
    Arch Pathol Lab Med; 2006 Oct; 130(10):1440-5. PubMed ID: 17090184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proficiency testing of immunohistochemical biomarker assays in breast cancer.
    Wasielewski Rv; Hasselmann S; Rüschoff J; Fisseler-Eckhoff A; Kreipe H
    Virchows Arch; 2008 Dec; 453(6):537-43. PubMed ID: 18958494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in formalin-fixed breast carcinoma cell block preparations: correlation of results to corresponding tissue block (needle core and excision) samples.
    Kinsella MD; Birdsong GG; Siddiqui MT; Cohen C; Hanley KZ
    Diagn Cytopathol; 2013 Mar; 41(3):192-8. PubMed ID: 22611048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
    Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F
    Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-Saharan breast cancer cases: Private practice experience.
    Nwafor CC; Keshinro SO
    Niger J Clin Pract; 2015; 18(4):553-8. PubMed ID: 25966732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.